Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens

J. A. Sutcliffe, W. O'Brien, C. Fyfe, T. H. Grossman
J. A. Sutcliffe
Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. O'Brien
Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Fyfe
Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. H. Grossman
Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.01288-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/AAC.01288-13
PubMed 
23979750

Published By 
American Society for Microbiology Journals
History 
  • Received June 29, 2013
  • Returned for modification July 21, 2013
  • Accepted August 20, 2013
  • Published online October 11, 2013.

Copyright & Usage 
Copyright © 2013, American Society for Microbiology. All Rights Reserved.

Article Versions

  • Accepted Manuscript version (August 26, 2013).
  • You are viewing the most recent version of this article.

Author Information

  1. J. A. Sutcliffe,
  2. W. O'Brien,
  3. C. Fyfe and
  4. T. H. Grossman
  1. Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA
  • Address correspondence to J. A. Sutcliffe, jsutcliffe{at}tphase.com.

Article usage

Article usage: August 2013 to February 2021

Rendering graph...
AbstractFullPdf
Aug 2013149023
Sep 2013159053
Oct 20136062991
Nov 20133681649
Dec 20131311217
Jan 2014172925
Feb 20141181829
Mar 2014991433
Apr 20142213895
May 2014852354
Jun 2014722854
Jul 2014553135
Aug 2014462037
Sep 2014703641
Oct 2014562636
Nov 2014512541
Dec 2014773547
Jan 2015593833
Feb 2015413628
Mar 2015433337
Apr 2015293644
May 2015532839
Jun 2015602422
Jul 2015938534
Aug 20151038724
Sep 201510511036
Oct 2015374226
Nov 2015322617
Dec 2015173825
Jan 2016348925
Feb 2016195439
Mar 20166810737
Apr 2016269625
May 20164211036
Jun 2016298834
Jul 2016155229
Aug 2016244612
Sep 2016385321
Oct 2016326424
Nov 2016213920
Dec 2016202825
Jan 2017292020
Feb 2017447729
Mar 2017263123
Apr 201723538
May 2017262715
Jun 2017263612
Jul 2017325810
Aug 2017294319
Sep 2017143014
Oct 2017295623
Nov 2017208639
Dec 2017184417
Jan 2018236017
Feb 20181611024
Mar 2018187737
Apr 2018217541
May 2018195328
Jun 2018164018
Jul 2018169125
Aug 20182413040
Sep 201822512573
Oct 20181810351
Nov 2018610728
Dec 201879725
Jan 20191011845
Feb 2019178831
Mar 20191912256
Apr 20191611938
May 2019158029
Jun 201996729
Jul 201997519
Aug 201984132
Sep 201956219
Oct 2019116320
Nov 20191013821
Dec 2019105910
Jan 2020126125
Feb 2020115827
Mar 2020274429
Apr 2020139742
May 2020129136
Jun 2020148245
Jul 202066511
Aug 202072822
Sep 202024318
Oct 20201110823
Nov 2020126024
Dec 2020186430
Jan 202165028
Feb 202155613
PreviousNext
Back to top
Download PDF
Citation Tools
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
J. A. Sutcliffe, W. O'Brien, C. Fyfe, T. H. Grossman
Antimicrobial Agents and Chemotherapy Oct 2013, 57 (11) 5548-5558; DOI: 10.1128/AAC.01288-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
J. A. Sutcliffe, W. O'Brien, C. Fyfe, T. H. Grossman
Antimicrobial Agents and Chemotherapy Oct 2013, 57 (11) 5548-5558; DOI: 10.1128/AAC.01288-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596